You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恒指升幅扩至逾300点 传统地产、医药、舜宇、美团及申洲领涨
阿思达克 03-30 11:20
美股昨晚个别发展,达拉斯联储3月制造业指数意外续急升至28.9逾两年半高,道指在波音及医保板块支持逆市续升近百点曾高见33,259纪录高;但美国有对冲基金「爆煲」导致多间银行损手,加上美国10年期债息再度升破1.7%,费城半导体指数吐近1.7%,拖累纳指及标普回吐0.6%及0.1%结束两连涨。美股期货全面窄幅微跌。亚太区股市今早个别发展,但除韩股、深成及港股升1.1%外,其余升跌均少於1%。

恒指继昨天反覆靠稳後,今早高开214点或近0.8%报28,552,早段曾回顺至28,371拒绝再下,再度抽高突破10天线(28,605),最高见28,675,现造28,659,续升321点或1.1%,成交额811亿元。

蓝筹股普遍造好,申洲(02313.HK)全年盈利微升0.2%但末期股息年增10%至1.1元,多间外资行绩後均予申洲正面评级,目标价介乎173.6-196元不等。该股今早扭七跌重越百天线,最多急涨10%至159.9元(受制10天线160元),现造155.9元,回升7.5%。

阿里巴巴(09988.HK)、海底捞(06862.HK)、绩後获多间大行削价美团(03690.HK)及舜宇(02382.HK)升3.5%-5%,分别高见225.2元、54.5元、295元及182.5元。

获野村重申「买入」评级仍看116.8元的药明生物(02269.HK)、阿里健康(00241.HK)、附属新药获美国临床试验批准的石药(01093.HK)回升逾3%-5%,分别报高见101.5元、22.8元及9.63元,後者股价重越10天线(9.35元)。重磅股腾讯(00700.HK)及发布多项新产品的小米(01810.HK)升逾1%及2%,分别报618.5元及25.6元。

传统地产股新地(00016.HK)、新世界(00017.HK)、恒地(00012.HK)及九仓置业(01997.HK)升逾2%-3.5%,分别报118.7元、39.8元、35.05元及45.3元。

相反,内房润地(01109.HK)扭转昨天绩前炒高至41.3元纪录高位强势,股价回吐3.9%曾低见39.05元。公司去年多赚3.6%至298.1亿人民币,末期股息年增17.6%至1.102元人民币。此外,昨午公布全年多赚5.5%末期股息年增28%的中国海外(00688.HK)继昨天涨逾6%受制22元後,今天股价重失10天及牛熊线(20.9元及21.47元),最低见20.5元,现造20.6元,回吐5.5%。中海外与中国建筑(03311.HK)设合营发展珠海商住地。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account